Found: 218
Select item for more details and to access through your institution.
Simulated cost‐effectiveness of a novel precision‐guided dosing strategy in adult patients with Crohn's disease initiating infliximab maintenance therapy.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 4, p. 331, doi. 10.1002/phar.2915
- By:
- Publication type:
- Article
Analysis of the CC chemokine receptor 5 (CCR5) delta-32 polymorphism in inflammatory bowel disease.
- Published in:
- Human Genetics, 2001, v. 108, n. 3, p. 190, doi. 10.1007/s004390100462
- By:
- Publication type:
- Article
Multi‐model averaging improves the performance of model‐guided infliximab dosing in patients with inflammatory bowel diseases.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 8, p. 1045, doi. 10.1002/psp4.12813
- By:
- Publication type:
- Article
Plasma cells are not restricted to the CD27+ phenotype: characterization of CD27-CD43+ antibody-secreting cells.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1165936
- By:
- Publication type:
- Article
SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study -- the BELCOMID study.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1126351
- By:
- Publication type:
- Article
Effects of fecal microbiota transplantation for recurrent Clostridium difficile infection in children on kidney replacement therapy: a pilot study.
- Published in:
- Pediatric Nephrology, 2024, v. 39, n. 4, p. 1201, doi. 10.1007/s00467-023-06168-6
- By:
- Publication type:
- Article
Effect of Mutant and Engineered High-Acetate-Producing Saccharomyces cerevisiae var. boulardii Strains in Dextran Sodium Sulphate-Induced Colitis.
- Published in:
- Nutrients, 2024, v. 16, n. 16, p. 2668, doi. 10.3390/nu16162668
- By:
- Publication type:
- Article
Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn's Disease.
- Published in:
- Digestive Diseases & Sciences, 2024, v. 69, n. 6, p. 2044, doi. 10.1007/s10620-024-08391-z
- By:
- Publication type:
- Article
The Crohn’s disease susceptibility gene DLG5 as a member of the CARD interaction network.
- Published in:
- Journal of Molecular Medicine, 2008, v. 86, n. 4, p. 423, doi. 10.1007/s00109-008-0307-5
- By:
- Publication type:
- Article
Pharmacokinetics of adalimumab in Crohn's disease.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus.
- Published in:
- Digestive Diseases, 2019, v. 37, n. 4, p. 266, doi. 10.1159/000496739
- By:
- Publication type:
- Article
Towards a Novel Molecular Classification of IBD.
- Published in:
- Digestive Diseases, 2012, v. 30, n. 4, p. 425, doi. 10.1159/000338147
- By:
- Publication type:
- Article
Emerging Biological Treatments in Inflammatory Bowel Diseases.
- Published in:
- Digestive Diseases, 2006, v. 24, n. 1/2, p. 131, doi. 10.1159/000090316
- By:
- Publication type:
- Article
New treatment options for inflammatory bowel diseases.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Development and validation of an optical biosensor for rapid monitoring of adalimumab in serum of patients with Crohn's disease.
- Published in:
- Drug Testing & Analysis, 2018, v. 10, n. 3, p. 592, doi. 10.1002/dta.2250
- By:
- Publication type:
- Article
Validation of a sample pretreatment protocol to convert a drug-sensitive into a drug-tolerant anti-infliximab antibody immunoassay.
- Published in:
- Drug Testing & Analysis, 2017, v. 9, n. 2, p. 243, doi. 10.1002/dta.1968
- By:
- Publication type:
- Article
Golimumab Dried Blood Spot Analysis (GOUDA): a Prospective Trial Showing Excellent Correlation with Venepuncture Samples and More Detailed Pharmacokinetic Information.
- Published in:
- AAPS Journal, 2019, v. 21, n. 1, p. 1, doi. 10.1208/s12248-018-0282-x
- By:
- Publication type:
- Article
PR3-anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Evidence of Crohn's disease-related anti-glycoprotein 2 antibodies in patients with celiac disease.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2015, v. 53, n. 9, p. 1349, doi. 10.1515/cclm-2014-0238
- By:
- Publication type:
- Article
Evaluation of serum cytokines and acute phase proteins as possible pharmacodynamic biomarkers to monitor endoscopic remission during ustekinumab therapy in patients with Crohn's disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, p. 1, doi. 10.1177/17562848231189110
- By:
- Publication type:
- Article
Evaluation of serum cytokines and acute phase proteins as possible pharmacodynamic biomarkers to monitor endoscopic remission during ustekinumab therapy in patients with Crohn's disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, v. 16, p. 1, doi. 10.1177/17562848231189110
- By:
- Publication type:
- Article
Modified Mayo score versus Mayo score for evaluation of treatment efficacy in patients with ulcerative colitis: data from the tofacitinib OCTAVE program.
- Published in:
- Therapeutic Advances in Gastroenterology, 2022, p. 1, doi. 10.1177/17562848221136331
- By:
- Publication type:
- Article
Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD).
- Published in:
- Acta Gastro-Enterologica Belgica, 2015, v. 78, n. 1, p. 26
- By:
- Publication type:
- Article
Recent advances: personalised use of current Crohn's disease therapeutic options.
- Published in:
- Postgraduate Medical Journal, 2014, v. 89, n. 1061, p. 144, doi. 10.1136/postgradmedj-2012-303958rep
- By:
- Publication type:
- Article
Clinical versus biologic remission.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
Advanced Imaging in Gastrointestinal Endoscopy: A Literature Review of the Current State of the Art.
- Published in:
- GE Portuguese Journal of Gastroenterology, 2023, v. 30, n. 3, p. 1, doi. 10.1159/000527083
- By:
- Publication type:
- Article
Molecular Changes in the Non-Inflamed Terminal Ileum of Patients with Ulcerative Colitis.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 8, p. 1793, doi. 10.3390/cells9081793
- By:
- Publication type:
- Article
Computational Biology and Machine Learning Approaches to Understand Mechanistic Microbiome-Host Interactions.
- Published in:
- Frontiers in Microbiology, 2021, v. 11, p. N.PAG, doi. 10.3389/fmicb.2021.618856
- By:
- Publication type:
- Article
A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29998-8
- By:
- Publication type:
- Article
Vedolizumab trough level monitoring in inflammatory bowel disease: a state-of-the-art overview.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Fibrogenesis in chronic murine colitis is independent of innate lymphoid cells.
- Published in:
- Immunity, Inflammation & Disease, 2020, v. 8, n. 3, p. 393, doi. 10.1002/iid3.321
- By:
- Publication type:
- Article
Betting on quality indicators to improve inflammatory bowel disease surveillance outcome: All‐in or one to pick?
- Published in:
- Digestive Endoscopy, 2020, v. 32, n. 4, p. 523, doi. 10.1111/den.13586
- By:
- Publication type:
- Article
Fibrogenesis in Chronic DSS Colitis is Not Influenced by Neutralisation of Regulatory T Cells, of Major T Helper Cytokines or Absence of IL-13.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-46472-6
- By:
- Publication type:
- Article
Etrolizumab for the Treatment of Ulcerative Colitis and Crohn's Disease: An Overview of the Phase 3 Clinical Program.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Optimizing Anti-TNF-α Therapy in IBD.
- Published in:
- Journal of Pediatric Gastroenterology & Nutrition, 2006, v. 43, p. S35, doi. 10.1097/01.mpg.0000256224.70396.ef
- By:
- Publication type:
- Article
New and Old Serological Markers in IBD.
- Published in:
- Journal of Pediatric Gastroenterology & Nutrition, 2006, v. 43, p. S21, doi. 10.1097/01.mpg.0000256209.19709.6f
- By:
- Publication type:
- Article
Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis.
- Published in:
- Crohn's & Colitis 360, 2023, v. 5, n. 2, p. 1, doi. 10.1093/crocol/otad009
- By:
- Publication type:
- Article
Clinical Effect of Mirikizumab Treatment on Bowel Urgency in Patients with Moderately to Severely Active Ulcerative Colitis and the Clinical Relevance of Bowel Urgency Improvement for Disease Remission.
- Published in:
- Crohn's & Colitis 360, 2023, v. 5, n. 1, p. 1, doi. 10.1093/crocol/otac044
- By:
- Publication type:
- Article
Machine learning-based detection of immune-mediated diseases from genome-wide cell-free DNA sequencing datasets.
- Published in:
- NPJ Genomic Medicine, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41525-022-00325-w
- By:
- Publication type:
- Article
ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1002629
- By:
- Publication type:
- Article
How to place the duality of specific MMP-9 inhibition for treatment of inflammatory bowel diseases into clinical opportunities?
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.983964
- By:
- Publication type:
- Article
Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain?
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.754413
- By:
- Publication type:
- Article
Temporal variability in quantitative human gut microbiome profiles and implications for clinical research.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27098-7
- By:
- Publication type:
- Article
Let Food Be Thy Medicine—Its Role in Crohn's Disease.
- Published in:
- Nutrients, 2021, v. 13, n. 3, p. 832, doi. 10.3390/nu13030832
- By:
- Publication type:
- Article
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 8, p. 1270, doi. 10.1093/ecco-jcc/jjae038
- By:
- Publication type:
- Article
Disease Acceptance, but not Perceived Control, is Uniquely Associated with Inflammatory Bowel Disease-related Disability.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 7, p. 1025, doi. 10.1093/ecco-jcc/jjae025
- By:
- Publication type:
- Article
Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 6, p. 885, doi. 10.1093/ecco-jcc/jjae007
- By:
- Publication type:
- Article
Outcomes and Endpoints of Postoperative Recurrence in Crohn's Disease: Systematic Review and Consensus Conference.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 6, p. 943, doi. 10.1093/ecco-jcc/jjad205
- By:
- Publication type:
- Article
Efficacy and Safety of the Anti-mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 5, p. 708, doi. 10.1093/ecco-jcc/jjad199
- By:
- Publication type:
- Article